Business
Press Release Aug 20 2025
Natco Pharma Limited has informed the Exchange regarding a press release dated August 20, 2025, titled "NATCO launches Bosentan Tablets for Oral Suspension (generic of Tracleer®) in the United States with 180-day exclusivity".
About this update from Natco Pharma Limited
[{"type":"text","content":" Natco Pharma Limited has informed the Exchange regarding a press release dated August 20, 2025, titled \"NATCO launches Bosentan Tablets for Oral Suspension (generic of Tracleer®) in the United States with 180-day exclusivity\". View Attachment","length":383,"tagName":"div"}]